Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study

Compared to clopidogrel, prasugrel has a lower incidence of ischemic events following percutaneous coronary intervention (PCI) because of an early reduction during the acute phase in P2Y12 reaction units (PRU). The objective of this study was to compare the antiplatelet effect and vascular endotheli...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Heart Vessels
Main Authors: Masuyama, Taiki, Sakuma, Masashi, Waku, Ryutaro, Hirose, Suguru, Kitahara, Keijiro, Naganuma, Jin, Yazawa, Hiroko, Toyoda, Shigeru, Abe, Shichiro, Nakajima, Toshiaki, Inoue, Teruo
Format: Artigo
Jezik:Inglês
Izdano: Springer Japan 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7940291/
https://ncbi.nlm.nih.gov/pubmed/33113567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00380-020-01714-w
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki